Posts Tagged ‘transactions-prior’

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in $6 Million Public Offering of Common Stock

By Sichenzia Ross Ference LLP | June 22, 2020

Document Security Systems, Inc.

$6,000,000

Common Stock

June 2020

Read More

Sichenzia Ross Ference LLP Represents Aegis Capital as Sole Bookrunner in $5.4 Million Public Offering of Digital Ally, Inc. Common Stock

By Sichenzia Ross Ference LLP | June 14, 2020

Digital Ally, Inc.

$5,400,000

Common Stock

June 2020

Read More

Sichenzia Ross Ference LLP Represents Aegis Capital as Sole Bookrunner in $5.1 Million Public Offering of Digital Ally, Inc. Common Stock

By Sichenzia Ross Ference LLP | June 5, 2020

Digital Ally, Inc.

$5,100,000

Common Stock

June 2020

Read More

Sichenzia Ross Ference LLP Represents Genetic Technologies Limited in $8 Million Public Offering

By Sichenzia Ross Ference LLP | May 28, 2020

Genetic Technologies Limited

$8,000,000

American Depository Shares

May 2020

Read More

Sichenzia Ross Ference LLP Represents Relmada Therapeutics, Inc. in $75 Million At-The-Market Offering

By Sichenzia Ross Ference LLP | May 26, 2020

Relmada Therapeutics

$75,000,000

At-The-Market Offering

May 2020

Read More

Sichenzia Ross Ference LLP Represents Pareteum Corporation in $3.75 Million Offering of Series C Preferred Stock

By Sichenzia Ross Ference LLP | May 25, 2020

Pareteum Corporation

$3,750,000

Series C Redeemable Preferred Stock

March 2020

Read More

Sichenzia Ross Ference LLP Represents ThinkEquity in $5 Million Public Offering of Medigus Ltd 

By Sichenzia Ross Ference LLP | May 22, 2020

Medigus Ltd.

$5,000,000

ADSs and Warrants

May 2020

Read More

Sichenzia Ross Ference LLP Represents Vuzix Corporation in $11,250,000 Registered Direct Offering

By Sichenzia Ross Ference LLP | May 13, 2020

Vuzix Corporation

$11,250,000

Direct Offering of Common Stock

May 2020

Read More

Sichenzia Ross Ference LLP Represents Lexaria Bioscience Corp. in $2 Million Private Placement 

By Sichenzia Ross Ference LLP | May 10, 2020

Lexaria Bioscience Corp.

$2,000,000

Common Stock and Warrants

May 2020

Read More

Sichenzia Ross Ference LLP Represents Aegis Capital in $3.15 Million Public Offering of Avinger, Inc. Common Stock

By Sichenzia Ross Ference LLP | May 9, 2020

Avinger, Inc.

$3,150,000

Common Stock

April 2020

Read More